Tag: following

Clinical Trials & Research

Regulatory Roadblock: FDA Places Clinical Hold on REGENXBIO’s RGX-121 Gene Therapy for Hunter Syndrome Following Asymptomatic Spine Findings

Executive Overview In a significant regulatory setback for the biotechnology sector, the United States Food and Drug Administration (FDA) has...

25 Aug 2026

Clinical Trials & Research

BioVie’s Stock Plummets 33% Following SUNRISE-PD Phase IIb Trial Data Release Utilizing Novel, Company-Created EPNIC-15 Endpoint

Executive Overview In the high-stakes world of biopharmaceutical research, the line separating scientific innovation from investor skepticism is razor-thin. On...

8 Aug 2026

Clinical Trials & Research

PepGen Advances PGN-EDODM1 to Maximum Planned Dose in Phase II FREEDOM2-DM1 Trial Following Favorable Safety Review

Executive Overview In a major development for the clinical advancement of genetic medicines targeting rare muscle disorders, biotechnology innovator PepGen...

7 Aug 2026